Skip to main content

Table 2 Results of multivariate Cox proportional-hazards analysis in testing set

From: Aberrant upregulation of 14-3-3ơ expression serves as an inferior prognostic biomarker for gastric cancer

Variable For death For progression-free survival
  Hazard Ratio 95%
confidence interval
p Hazard Ratio 95%
confidence interval
p
Age < 58.00
years (VS. ≥ 58 years)
1.101 0.637 to 1.902 0.731 1.056 0.577 to 1.936 0.859
Gender Male
(VS. Female)
0.772 0.408 to 1.461 0.427 1.049 0.525 to 2.094 0.892
Clinical stage
IV + III (VS. II +I)
3.391 1.156 to 9.949 0.026 5.220 1.529 to 17.823 0.008
Tumor invasion
T 4 + T 3 (VS. T 2 + T 1 )
1.066 0.320 to 3.553 0.917 0.730 0.206 to 2.585 0.626
Nodal stage N 3 + N 2
(VS. N 1 + N 0 )
0.705 0.387 to 1.282 0.251 0.735 0.373 to 1.448 0.373
Differentiation
Low (VS. High)
0.862 0.437 to 1.701 0.668 0.936 0.442 to 1.982 0.863
14-3-3σ
Positive (VS. Negative)
4.527 2.274 to 9.012 0.000 3.582 1.717 to 7.475 0.001